Nov 14 (Reuters) - U.S. equity funds witnessed a sharp cooling of demand in the week through November 12 as investors grew wary about the durability of the artificial intelligence-driven market rally and indications of weakening labour market conditions in October. U.S. investors bought just $1.15 billion worth of equity funds during the week, their smallest weekly net purchase since...

Overview * Scholar Rock ( SRRK ) Q3 net loss widens to $102.2 mln, no revenue recorded * Operating expenses increased due to apitegromab launch readiness * Company expects cash reserves to fund operations into 2027 Outlook * Scholar Rock ( SRRK ) anticipates U.S. launch of apitegromab in 2026 * Company reserves commercial capacity for apitegromab starting Q1 2026...

Overview * Marker Q3 net loss narrows to $2 mln from $2.3 mln yr/yr * MT-601 shows 66% response rate in relapsed NHL patients * Company raises $10 mln through ATM facility, extending cash runway into 2026 Outlook * Marker plans to share additional MT-601 data in the first half of 2026 * Company focuses on enrolling patients in MT-601...

(Reuters) -Merck ( MRK ) will acquire Cidara Therapeutics ( CDTX ) in a nearly $9.2 billion deal, the companies said, gaining access to an experimental drug for flu prevention. The move adds to a growing list of high-profile transactions over the past decade by U.S. pharmaceutical companies to acquire promising therapies in fields ranging from oncology, neurology to rare...